Alder Biopharmaceuticals, Inc. (ALDR)

12.68
NASDAQ
Prev Close 12.68
Day Low/High 0.00 / 0.00
52 Wk Low/High 9.44 / 20.87
Exchange NASDAQ
Shares Outstanding 81.54B
Market Cap 1.03B
Div & Yield N.A. (N.A)

Latest News

First Week Of ALDR May 17th Options Trading

First Week Of ALDR May 17th Options Trading

Investors in Alder Biopharmaceuticals Inc saw new options begin trading this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALDR options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

First Week Of ALDR July 2019 Options Trading

First Week Of ALDR July 2019 Options Trading

Investors in Alder Biopharmaceuticals Inc saw new options become available this week, for the July 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 232 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Oversold Conditions For Alder Biopharmaceuticals (ALDR)

Oversold Conditions For Alder Biopharmaceuticals (ALDR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of ALDR April 2019 Options Trading

First Week Of ALDR April 2019 Options Trading

Investors in Alder Biopharmaceuticals Inc saw new options become available this week, for the April 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week Of January 2019 Options Trading For Alder Biopharmaceuticals (ALDR)

Investors in Alder Biopharmaceuticals Inc saw new options begin trading this week, for the January 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week Of ALDR June 15th Options Trading

Investors in Alder Biopharmaceuticals Inc saw new options become available this week, for the June 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALDR options chain for the new June 15th contracts and identified the following call contract of particular interest.

Alder Biopharmaceuticals Enters Oversold Territory (ALDR)

Alder Biopharmaceuticals Enters Oversold Territory (ALDR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of October 19th Options Trading For Alder Biopharmaceuticals (ALDR)

First Week of October 19th Options Trading For Alder Biopharmaceuticals (ALDR)

Investors in Alder Biopharmaceuticals Inc saw new options begin trading this week, for the October 19th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Alder BioPharmaceuticals, Inc. Announces Closing Of $250 Million Of 2.50% Convertible Senior Notes Due 2025

Alder BioPharmaceuticals, Inc. Announces Closing Of $250 Million Of 2.50% Convertible Senior Notes Due 2025

Augments $100 million in gross proceeds received in the $250 million January 2018 committed equity financing with Redmile Group, LLC investors; remaining $150 million undrawn capacity terminated

First Week of ALDR March 16th Options Trading

First Week of ALDR March 16th Options Trading

Investors in Alder Biopharmaceuticals Inc saw new options become available this week, for the March 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALDR options chain for the new March 16th contracts and identified one put and one call contract of particular interest.

Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

Even with Monday's sharp reversal, Jim Cramer says he still likes this market.

How High Can This Market Go?: Cramer's 'Mad Money' Recap (Friday 1/12/18)

How High Can This Market Go?: Cramer's 'Mad Money' Recap (Friday 1/12/18)

Jim Cramer marvels at the market leadership from financials, airlines and even tech stocks. Check out his game plan for next week.

Alder BioPharmaceuticals: Cramer's Top Takeaways

Alder BioPharmaceuticals: Cramer's Top Takeaways

Randall Schatzman, co-founder, president and CEO of Alder BioPharmaceuticals, tells Jim Cramer about migraine treatment Eptinezumab.

First Week of December 15th Options Trading For Alder Biopharmaceuticals (ALDR)

First Week of December 15th Options Trading For Alder Biopharmaceuticals (ALDR)

Investors in Alder Biopharmaceuticals Inc saw new options begin trading this week, for the December 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALDR options chain for the new December 15th contracts and identified the following put contract of particular interest.

ALDR: Insiders vs. Shorts

ALDR: Insiders vs. Shorts

The most recent short interest data was recently released for the 10/31/2017 settlement date, and Alder Biopharmaceuticals Inc is one of the most shorted stocks of the Russell 3000, based on 7.31 "days to cover" versus the median component at 5.18. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.